Abstract:Specific inhibition of P-glycoprotein (Pgp) expression, which is encoded by multidrug resistance gene-1 (MDR1), is considered a well-respected strategy to overcome multidrug resistance (MDR). Deoxyribozymes (DRz) are catalytic nucleic acids that could cleave a target RNA in sequence-specific manner. However, it is difficult to select an effective target site for DRz in living cells. In this study, target sites of DRz were screened according to MDR1 mRNA secondary structure by RNA structure analysis software. Twelve target sites on the surface of MDR1 mRNA were selected. Accordingly, 12 DRzs were synthesized and their suppression effect on the MDR phenotype in breast cancer cells was confirmed. The results showed that 4 (DRz 2, 3, 4, 9) of the 12 DRzs could, in a dose-dependent response, significantly suppress MDR1 mRNA expression and restore chemosensitivity in breast cancer cells with MDR phenotype. This was especially true of DRz 3, which targets the 141 site purine-pyrimidine dinucleotide. Compared with antisense oligonucleotide or anti-miR-27a inhibitor, DRz 3 was more efficient in suppressing MDR1 mRNA and Pgp protein expression or inhibiting Pgp function. The chemosensitivity assay also proved DRz 3 to be the best one to reverse the MDR phenotype. The present study suggests that screening targets of DRzs according to MDR1 mRNA secondary structure could be a useful method to obtain workable ones. We provide evidence that DRzs (DRz 2, 3, 4, 9) are highly efficient at reversing the MDR phenotype in breast carcinoma cells and restoring chemosensitivity.

In vitro cleavage of mdrl mrna fragment by synthetic ribozyme (rz) and transcribed ribozyme from tna-trimming plasmid

Invitro Cleavage of Hpv16 E6 and E7 Rna Fragments by Synthetic Ribozymes and Transcribed Ribozymes from Rna-Trimming Plasmids

Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer]

Ribozyme Cleavage Leads to Decreased Expression of Fibroblast Growth Factor Receptor 3 in Human Multiple Myeloma Cells, Which is Associated with Apoptosis and Downregulation of Vascular Endothelial Growth Factor

Reversal MDR in Breast Carcinoma Cells by Transfection of Ribozyme Designed According the Secondary Structure of Mdr1 Mrna.

Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme]

Screening of deoxyribozyme with high reversal efficiency against multidrug resistance in breast carcinoma cells.

Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.

Restoration of Chemosensitivity in Cancer Cells with MDR Phenotype by Deoxyribozyme, Compared with Ribozyme.

Ribozyme-Spherical Nucleic Acids.

Expression of Anti-Pcna Mrna Ribozyme by T7 Vaccinia Virus System in Hela Cells

Ribozyme-Mediated Cleavage of the Estrogen Receptor Messenger Rna and Inhibition of Receptor Function in Target Cells

Inhibition of Telomerase in Tumor Cells by Ribozyme Targeting Telomerase RNA Component.

Synthesizing, Cloning, Expressing of Anti-Vascular Endothelial Growth Factor Hairpin Ribozyme Gene and Assaying of Its Activity

G-Quadruplex mRNAs Silencing with Inducible Ribonuclease Targeting Chimera for Precision Tumor Therapy

[In Vitro Cleavage Action of C-Erbb-2 Oncogene-Specific Ribozyme].

Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c- myc specific ribozyme

Ribosomal RNA transcription governs splicing through ribosomal protein RPL22

Study on Telomerase Inhibition by Ribozyme Targeted to Telomerase RNA Component

Expression Andin Vitrocleavage Activity of Anti-Caspase-7 Hammerhead Ribozymes

Cleavage activity of ribozymes on a target RNA of tobacco mosaic virus in E. coli]